GEA
ACB

Glen Eagle Advisors’s Aurora Cannabis ACB Stock Holding History

Glen Eagle Advisors’s Portfolio ACB Stock Details ACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$59 – 1108
2024
Q3 		$59 Hold
10
– – ﹤0.01% 1138
2024
Q2 		$46 Hold
10
– – ﹤0.01% 1123
2024
Q1 		$44 Buy
+10
New +$39 ﹤0.01% 1091

Other funds holding ACB

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Glen Eagle Advisors's ACB Position: Q4 2024 in Review

Glen Eagle Advisors sold out of Aurora Cannabis (ACB) in Q4 2024, closing a stake of 10 shares — an estimated $59 sold.

Glen Eagle Advisors first reported a position in ACB in Q1 2024 and held it in 3 quarters. The position peaked at $59 in Q3 2024. 168 funds tracked by Wall St. Rank hold ACB as of Q4 2024.

  • Glen Eagle Advisors reported no remaining Aurora Cannabis position as of Q4 2024 after selling out during the quarter.
  • Glen Eagle Advisors sold 10 Aurora Cannabis shares in Q4 2024, an estimated $59.
  • Glen Eagle Advisors first reported a position in Aurora Cannabis in Q1 2024 and held it in 3 quarters.
  • Glen Eagle Advisors's Aurora Cannabis position peaked at $59 in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Aurora Cannabis as of Q4 2024.

Based on Glen Eagle Advisors's 13F filing for Q4 2024, filed 18 Feb 2025.